Investor Relations

Press Release

July 9, 2018

Amphastar Announces Expansion of Amphastar Nanjing Pharmaceuticals Inc.

More
June 19, 2018

Amphastar Announces Approval for Isoproterenol Hydrochloride Injection, USP

More
June 4, 2018

Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference 2018

More
June 4, 2018

Amphastar Pharmaceuticals Receives FDA Approval for Semi-Purified Heparin at Amphastar Nanjing Pharmaceuticals

More
May 14, 2018

Amphastar Pharmaceuticals Receives FDA Approval for Calcium Chloride Injection

More
May 10, 2018

Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2018

More
May 9, 2018

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018

More
May 3, 2018

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2018

More
March 26, 2018

Amphastar Pharmaceuticals to Present at the Needham’s 17th Annual Healthcare Conference

More
March 21, 2018

Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.

More
Youtube